Related Experiment Video
Updated: May 12, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Cross-sectional Hospital-based Investigation on Clinical Characteristics of Pediatric Staphylococcus aureus Isolates
LuWei Wang1, Jing-Hui Zhen1, Fang Dong1
1Department of Clinical Laboratory Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) is a growing concern in children, with high resistance rates to common antibiotics like penicillin and erythromycin observed in Beijing. Ongoing surveillance and revised treatment guidelines are crucial to combatting its spread.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Staphylococcus aureus (S. aureus) is a common pathogen in children, with increasing antibiotic resistance.
- Methicillin-resistant Staphylococcus aureus (MRSA) has become a significant cause of healthcare-associated and community-acquired infections globally.
- Antimicrobial resistance patterns of S. aureus in pediatric populations require continuous monitoring.
Purpose of the Study:
- To analyze the prevalence and antimicrobial resistance patterns of S. aureus infections in children in Beijing, China.
- To highlight the significance of S. aureus as a pediatric pathogen.
- To provide data for revising clinical treatment guidelines.
Main Methods:
- Retrospective analysis of S. aureus isolates from 2013-2022 at Beijing Children's Hospital.
- Antimicrobial susceptibility testing using Vitek 2 automated system or Kirby-Bauer disc diffusion.
- Analysis of patient demographics, specimen sources, and isolate resistance profiles.
Main Results:
- S. aureus was identified in 6477 isolates from 433,081 specimens.
- Infants under one year old accounted for the majority of S. aureus infections (37.9%).
- High resistance rates were observed for penicillin (89.5%) and erythromycin (73.8%), while low rates were seen for linezolid and vancomycin (0.0%).
- The MRSA detection rate was 27.8%, with higher prevalence in newborns, ICUs, and sterile body fluids.
- Lower respiratory tract specimens were most common, but ear secretions showed the highest positive rate.
Conclusions:
- S. aureus remains a significant pathogen in children, with notable antimicrobial resistance.
- Elevated MRSA rates in vulnerable populations necessitate updated treatment guidelines and surveillance.
- Targeted interventions are essential to mitigate the spread of antimicrobial-resistant S. aureus.
Background:
Staphylococcus aureus (S. aureus) was a prevalent pathogenic bacterium among children. Due to the extensive use of antibiotics, the sensitivity of S. aureus to these drugs has gradually declined. Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged and spread worldwide, becoming a primary cause of both healthcare-associated (HA) and community-acquired (CA) infections. This retrospective study aimed to highlight the significance of S. aureus among bacteria isolated from children in Beijing, China, and to elucidate its antimicrobial resistance patterns.
Methods:
Data on all S. aureus infections from 2013 to 2022 were collected from the microbiology department of Beijing Children's Hospital. Only the first isolate from the same kind of specimen was analyzed. Antimicrobial susceptibility tests were carried out by Vitek 2 automated system (bio Mérieux, France) or Kirby-Bauer disc diffusion method, according to the guidelines recommended by the Clinical and Laboratory Standards Institute (CLSI).
Results:
During the decade-long research period, a total of 47,062 bacterial isolates were isolated from 433,081 submitted specimens, with 6477 of these isolates identified as S. aureus. The majority of patients with S. aureus infections belonged to the age group of infants under one-year-old, accounting for 37.9% of cases. S. aureus isolates were predominantly found in the Pneumology Department, and the most common source of these isolates was lower respiratory tract specimens, comprising 34.3% of the total. The resistance rates of S. aureus to penicillin and erythromycin were notably high, at 89.5% and 73.8%, respectively. In contrast, the resistance rates to linezolid, vancomycin, rifampicin, and moxifloxacin were remarkably low, at 0.0%, 0.0%, 1.3%, and 3.9%, respectively. The detection rate of MRSA was 27.8%. MRSA isolates were predominantly found in the newborn group, ICU, and sterile body fluids.
Conclusion:
In our study, the most prevalent specimen type was derived from the lower respiratory tract, whereas the highest positive rate was observed in ear secretions. These findings underscored the pressing necessity for ongoing antimicrobial resistance (AMR) surveillance and the revision of treatment guidelines, particularly given the elevated detection of MRSA in ICU wards, sterile body fluids, and the neonatal age group. MRSA exhibited significant resistance to all β-lactam antibiotics, erythromycin, and ciprofloxacin. Therefore, future research endeavors should prioritize examining specific antimicrobial resistance populations and potential intervention strategies, as these were vital in mitigating the dissemination of antimicrobial-resistant isolates.
Related Concept Videos
Investigation of Disease Outbreaks
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance

